7) Tahara, H et al:Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol 154:6466-6474, 1995
8) Atkins, B A, Robertson, M J, Gordon, M et al:Phase I evaluation of intravenous recombinant human interleukin-12 (rhlL-12) in patients with advanced malignancies. Clin. Cancer Res 3:409-417, 1997
9) Tahara, H et al:Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor immunity to a murine melanoma in vivo. Cancer Res 54:182-189, 1994
10) Zitvogel, L et al:Cancer immunotherapy of established tumors with IL-12-effective delivery by genetically engineered fibroblasts. J. Immunol 155:1393-1403, 1995
12) Couderc B, Zitvogel L, Douin-Echinard V, Djennane L, Tahara H, Farvre G, Lotze MT and Robbins P D:Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Therapy 5:163-175, 1998
16) Nishioka Y, Robbins P D, Lotze M T, and Tahara H Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res 59:4035-41, 1999